Affiliation:
1. Department of Infectious Diseases, University Hospital, Leiden, The Netherlands.
Abstract
Etoposide, an antitumor drug, had an effect in vitro against all strains of gram-positive bacteria studied but not against three gram-negative bacteria. The MICs ranged between 6.2 and 50 micrograms/ml. In short-term-growth experiments, etoposide had a bactericidal efficacy that was 10 to 50 times lower than that of cloxacillin.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference16 articles.
1. VP16-213 (etoposide). A critical review of its activity;Cavalli F.;Cancer Chemother. Pharmacol.,1982
2. Pharmacokinetics of VP16-213 in Lewis Iung carcinoma bearing mice;Colombo T.;Cancer Chemother. Pharmacol.,1982
3. Comparison of pharmacokinetics of VP16 in mice, rats and humans;Colombo T.;Proc. Am. Assoc. Cancer Res.,1983
4. Pharmacokinetics of VP16-213 given by different administration methods;D'Incalci M.;Cancer Chemother. Pharmacol.,1982
5. Pharmacokinetics of high-dose etoposide (VP-16-213) administered to cancer patients;Hande K. R.;Cancer Res.,1984
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献